Verisante Technology Price to Book Ratio 2012-2024 | VRSEF
Historical price to book ratio values for Verisante Technology (VRSEF) over the last 10 years. The current price to book ratio for Verisante Technology as of June 05, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Verisante Technology Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-06-04 | 0.00 | 0.00 | |
| 2024-12-31 | 0.01 | $0.00 | -4.17 |
| 2024-09-30 | 0.01 | $0.00 | -7.14 |
| 2024-06-30 | 0.00 | $0.00 | -7.67 |
| 2024-03-31 | 0.01 | $0.00 | 50.00 |
| 2023-12-31 | 0.00 | $0.00 | 0.00 |
| 2023-09-30 | 0.01 | $0.00 | 10.00 |
| 2023-06-30 | 0.01 | $0.00 | -6.25 |
| 2023-03-31 | 0.00 | $0.00 | -0.22 |
| 2022-12-31 | 0.01 | $0.00 | -108.00 |
| 2022-09-30 | 0.01 | $-0.06 | -0.17 |
| 2022-06-30 | 0.01 | $-0.12 | -0.07 |
| 2017-09-30 | 0.01 | $-0.09 | -0.16 |
| 2017-06-30 | 0.02 | $-0.07 | -0.29 |
| 2017-03-31 | 0.01 | $-0.05 | -0.21 |
| 2016-12-31 | 0.02 | $-0.02 | -1.20 |
| 2016-09-30 | 0.03 | $0.01 | 2.78 |
| 2016-06-30 | 0.02 | $0.04 | 0.50 |
| 2016-03-31 | 0.03 | $0.07 | 0.44 |
| 2015-12-31 | 0.04 | $0.11 | 0.41 |
| 2015-09-30 | 0.06 | $0.15 | 0.36 |
| 2015-06-30 | 0.09 | $0.20 | 0.46 |
| 2015-03-31 | 0.09 | $0.22 | 0.42 |
| 2014-12-31 | 0.08 | $0.33 | 0.25 |
| 2014-09-30 | 0.13 | $0.36 | 0.36 |
| 2014-06-30 | 0.14 | 0.00 | |
| 2014-03-31 | 0.17 | 0.00 | |
| 2013-12-31 | 0.22 | 0.00 | |
| 2013-09-30 | 0.22 | 0.00 | |
| 2013-06-30 | 0.32 | 0.00 | |
| 2013-03-31 | 0.51 | 0.00 | |
| 2012-12-31 | 0.52 | 0.00 | |
| 2012-09-30 | 0.59 | 0.00 | |
| 2012-06-30 | 0.46 | 0.00 | |
| 2012-03-31 | 0.64 | 0.00 | |
| 2011-12-31 | 0.64 | 0.00 | |
| 2011-09-30 | 0.67 | 0.00 | |
| 2011-06-30 | 0.73 | 0.00 | |
| 2011-03-31 | 0.61 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| Verisante Technology, Inc. operates as a medical device company engaged in the development of innovative systems for the early detection of cancer. It develops and offers a range of compact, non?invasive cancer detection devices for many of the most common cancers, including gastro?intestinal, colorectal and cervical cancers. The Company's Verisante Aura series is a novel multimodality imaging and spectroscopy system designed to aid in the early detection of skin cancer. Other product offered by the company includes Verisante Core series and Authenticare- a pre-production prototype of a pharmaceutical tablet analyzer for the authentication of solid dosage pharmaceuticals. Verisante Technology, Inc. is based in Vancouver, British Columbia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.979B | 87.59 |
| Thermo Fisher Scientific (TMO) | United States | $152.379B | 18.43 |
| Edwards Lifesciences (EW) | United States | $45.667B | 29.94 |
| Alcon (ALC) | Switzerland | $42.389B | 28.65 |
| IDEXX Laboratories (IDXX) | United States | $42.210B | 48.51 |
| DexCom (DXCM) | United States | $33.568B | 51.88 |
| IQVIA Holdings (IQV) | United States | $25.587B | 14.33 |
| Mettler-Toledo (MTD) | United States | $24.309B | 28.91 |
| STERIS (STE) | Ireland | $23.816B | 26.23 |
| Waters (WAT) | United States | $21.016B | 29.65 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.484B | 0.00 |
| Hologic (HOLX) | United States | $13.943B | 15.15 |
| Sysmex ADR (SSMXY) | Japan | $10.323B | 29.29 |
| Penumbra (PEN) | United States | $9.888B | 77.61 |
| Masimo (MASI) | United States | $8.836B | 32.59 |
| Globus Medical (GMED) | United States | $8.077B | 19.25 |
| Teleflex (TFX) | United States | $5.424B | 8.95 |
| Glaukos (GKOS) | United States | $5.198B | 0.00 |
| TransMedics (TMDX) | United States | $4.391B | 95.45 |
| Integer Holdings (ITGR) | United States | $4.193B | 21.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.410B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.425B | 14.44 |
| Nihon Kohden (NHNKY) | Japan | $2.244B | 25.74 |
| Veracyte (VCYT) | United States | $2.137B | 29.99 |
| Elekta AB (EKTAY) | Sweden | $1.968B | 17.69 |
| Alphatec Holdings (ATEC) | United States | $1.795B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.344B | 0.00 |
| Artivion (AORT) | United States | $1.224B | 114.64 |
| Pulse Biosciences (PLSE) | United States | $1.181B | 0.00 |
| OPKO Health (OPK) | United States | $1.067B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.018B | 5.41 |
| Beta Bionics (BBNX) | United States | $0.843B | 0.00 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| IRadimed (IRMD) | United States | $0.773B | 39.21 |
| RxSight (RXST) | United States | $0.620B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.577B | 8.97 |
| Delcath Systems (DCTH) | United States | $0.570B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.551B | 12.91 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.489B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.445B | 0.00 |
| NeuroPace (NPCE) | United States | $0.432B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.427B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.399B | 10.61 |
| ClearPoint Neuro (CLPT) | United States | $0.364B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.363B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.309B | 0.00 |
| Neuronetics (STIM) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.247B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.28 |
| Sight Sciences (SGHT) | United States | $0.219B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.207B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.159B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 48.90 |
| InspireMD (NSPR) | United States | $0.080B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.055B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Spectral AI (MDAI) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.12 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |